Initial evaluation 1. Sign consent form for the vaccine study entitled “Phase I -II Study of Combination Immunotherapy for the Generation of HER -2/neu (HER2) Specific Cytotoxic T Cells (CTL) in vivo” 2. Medical history and c omplete physical examination.